Trials / Completed
CompletedNCT00583713
An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry Parameters
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To evaluate and compare the effects on safety measures and clinical chemistry after BLI800 in two groups of patients and one group of healthy controls. The patient groups will be those with mild or moderate hepatic impairment or moderate renal disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BLI-800 | BLI-800 oral solution (two doses) |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-04-01
- Completion
- 2008-06-01
- First posted
- 2007-12-31
- Last updated
- 2010-11-11
- Results posted
- 2010-11-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00583713. Inclusion in this directory is not an endorsement.